Affiliate disclosure: vendor links in this article are affiliate links — The Peptide Catalog may earn a commission if you buy through them, at no additional cost to you.
Where These Numbers Come From
The Klow blend combines four peptides with established individual dosing protocols into fixed ratios that deliver standard doses per injection.
GHK-Cu (Pickart & Margolina, 2018): Activates 4,000+ genes for tissue remodeling, collagen synthesis, and stem cell recruitment. The 2.5 mg per injection is within standard research ranges.
KPV (Dalmasso et al., 2008): Alpha-MSH fragment that directly suppresses NF-kB — the master inflammatory switch. Transported via PepT1 into intestinal cells, providing gut-specific anti-inflammatory effects alongside systemic NF-kB inhibition (Brzoska et al., 2007).
BPC-157 (Sikiric et al., 2014): Angiogenesis driver through VEGF and nitric oxide modulation. 500 mcg per injection matches standalone protocols.
TB-500 (Malinda et al., 1999): Cell migration via LKKTET actin-binding domain. 500 mcg per injection aligns with standard daily dosing.
The four peptides cover distinct phases of healing: inflammation control (KPV), vascularization (BPC-157), cell recruitment (TB-500), and tissue remodeling (GHK-Cu).
Klow vs Glow vs Wolverine Stack
Feature Klow (80mg) Glow (70mg) Wolverine Stack (20mg) BPC-157 10 mg 10 mg 10 mg TB-500 10 mg 10 mg 10 mg GHK-Cu 50 mg 50 mg -- KPV 10 mg -- -- NF-kB targeting Direct (KPV) Indirect None Best for Repair + inflammation + gut Repair + collagen Pure injury recovery
Klow is commonly chosen by: users whose protocols target systemic inflammation, gut issues, autoimmune-related tissue damage, or post-surgical recovery — community sources describe KPV's NF-kB mechanism as the differentiator in these contexts. Glow is commonly chosen by: users focused on musculoskeletal repair or collagen support without a significant inflammatory component. Wolverine is commonly chosen by: users whose protocols center on acute injury recovery without a collagen or anti-aging layer.
Side Effects & Safety
Community-reported side effects for this blend combination include:
Injection site redness — community sources typically describe mild redness resolving within 30-60 minutes Slight drowsiness — self-reported in the first week, attributed by community sources to GHK-Cu Mild warmth or flushing — reported by users, attributed to KPV's alpha-MSH fragment activity; described as transient Nausea — community sources most commonly report this in the first 2-3 injections, described as dose-dependent Headache — occasionally self-reported; community discussion attributes this to BPC-157's nitric oxide modulation All four peptides are research compounds without FDA approval No human clinical trials for this specific combination
Ready to buy? Compare verified vendors on our best Klow Blend sources page, or browse all coupon codes for up to 50% off.
mg to Units Conversion
On a standard 100-unit insulin syringe, each "unit" equals 0.01 mL (so 100 units = 1 mL). Because this is a pre-mixed blend, a single draw delivers all components together in fixed ratio. The KLOW blend is dosed by total milligrams drawn; the four components stay in their fixed manufacturing ratio.
Reconstitution A: 80 mg vial + 2 mL BAC water (40 mg/mL total) — the standard dilution from the Quick Reference above.
Total blend dose Volume (mL) Units (insulin syringe) 2 mg 0.05 mL 5 units 4 mg 0.1 mL 10 units 6 mg 0.15 mL 15 units 8 mg 0.2 mL 20 units
Reconstitution B: 80 mg vial + 3 mL BAC water (26.7 mg/mL total) — more BAC water for larger, easier-to-measure draws.
Total blend dose Volume (mL) Units (insulin syringe) 2 mg 0.075 mL 7.5 units 4 mg 0.15 mL 15 units 6 mg 0.225 mL 22.5 units 8 mg 0.3 mL 30 units
These conversions reflect the dilutions documented in community reconstitution protocols. They report how the math is described, not a recommended dosing schedule.